Filing Details

Accession Number:
0001140361-21-006649
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-03-01 16:23:46
Reporting Period:
2021-02-25
Accepted Time:
2021-03-01 16:23:46
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1755237 Cyclerion Therapeutics Inc. CYCN Pharmaceutical Preparations (2834) 831895370
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1839068 Anjeza Gjino C/O Cyclerion Therapeutics, Inc.
245 First Street, 18Th Floor
Cambridge MA 02142
Chief Financial Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2021-02-25 1,824 $4.00 31,599 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This sale was made to cover tax withholding obligations in connection with the vesting and settlement of approximately 25% of the reporting person's restricted stock units granted on April 1, 2019.
  2. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.80 to $4.00, inclusive. The reporting person will provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote.